ID   HyCyte BxPC-3 stable cell line for hANXA2 overexpression
AC   CVCL_F4U2
SY   BxPC-3 stable cell line for hANXA2 overexpression
DR   Hysigen; CGSC-M34991
CC   Population: Caucasian.
CC   Characteristics: Transduced with pLV[Exp]-CMV>hANXA2[NM_004039.3]-EF1A>copGFP:T2A:Puro-WPRE.
CC   Doubling time: 36-48 hours (Hysigen=CGSC-M34991).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:537; ANXA2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 25-06-26; Last updated: 25-06-26; Version: 1
//